Françoise Redini Selected Research

Françoise Redini Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 10/2006
21	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 12/2005
11	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2005
8	Bone Resorption 01/2016 - 11/2003
7	Ewing Sarcoma (Sarcoma, Ewing) 12/2016 - 10/2010
5	Osteolysis 06/2015 - 11/2003
4	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 01/2012
3	Chondrosarcoma 11/2012 - 09/2009
2	Bone Neoplasms (Bone Cancer) 03/2022 - 01/2019
2	Bone Diseases (Bone Disease) 11/2008 - 12/2001
1	Hypoxia (Hypoxemia) 03/2022
1	Breast Neoplasms (Breast Cancer) 11/2019
1	Necrosis 01/2017
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 09/2016
1	Adenocarcinoma 01/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014
1	Inflammation (Inflammations) 06/2013
1	Neuroblastoma 11/2012
1	Medulloblastoma 11/2012
1	Glioma (Gliomas) 11/2012
1	Carcinoma (Carcinomatosis) 02/2008

Drug/Important Bio-Agent (IBA)

7	Zoledronic Acid (Zometa)FDA Link 01/2019 - 12/2005
5	Diphosphonates (Bisphosphonates)IBA 09/2016 - 12/2005
5	OsteoprotegerinIBA 09/2013 - 12/2001
4	CytokinesIBA 01/2018 - 01/2015
4	Proteoglycans (Proteoglycan)IBA 04/2013 - 09/2009
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2016 - 01/2011
2	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2018
2	CaspasesIBA 01/2018 - 12/2016
2	TNF-Related Apoptosis-Inducing LigandIBA 01/2018 - 12/2016
2	LigandsIBA 01/2018 - 11/2008
2	Ifosfamide FDA LinkGeneric 01/2018 - 01/2017
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2016 - 10/2014
2	mifamurtideIBA 01/2016 - 02/2011
2	Cytostatic AgentsIBA 02/2015 - 11/2012
2	EWS-FLI fusion proteinIBA 04/2013 - 11/2012
2	EnzymesIBA 11/2008 - 11/2003
2	RANK LigandIBA 10/2006 - 11/2003
1	2-toluenesulfonamide (OTS)IBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	SialomucinsIBA 01/2022
1	Verteporfin (Visudyne)FDA Link 12/2020
1	Epinephrine (Adrenaline)FDA LinkGeneric 11/2019
1	Conditioned Culture MediaIBA 11/2019
1	LipidsIBA 11/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	ProdrugsIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Apoptosis Inducing FactorIBA 12/2016
1	Ethanolamine (Colamine)IBA 01/2016
1	halofuginoneIBA 06/2015
1	Adenosine Triphosphate (ATP)IBA 02/2015
1	AlpelisibIBA 02/2015
1	SD-208IBA 10/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	AerosolsIBA 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	Imatinib Mesylate (Gleevec)FDA Link 01/2014
1	Tyrosine Kinase InhibitorsIBA 01/2014
1	DisintegrinsIBA 06/2013
1	Metalloproteases (Metalloproteinases)IBA 06/2013
1	Connexin 43 (Connexin43)IBA 04/2013
1	Transcription Factors (Transcription Factor)IBA 04/2013
1	Proteins (Proteins, Gene)FDA Link 11/2012
1	Oncostatin MIBA 11/2012
1	Lovastatin (Mevacor)FDA LinkGeneric 02/2012
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 02/2012
1	apomine (SR 45023A)IBA 02/2012
1	Heparin (Liquaemin)FDA LinkGeneric 01/2011
1	GlycosaminoglycansIBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	NF-kappa B (NF-kB)IBA 11/2008
1	Cathepsin KIBA 11/2008
1	Caspase 3 (Caspase-3)IBA 02/2008
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 10/2006
1	bone resorption factorIBA 11/2003
1	ImmunosorbentsIBA 11/2003

Therapy/Procedure

11	Therapeutics 01/2016 - 02/2007
7	Drug Therapy (Chemotherapy) 01/2022 - 10/2010
1	Oral Administration 01/2014
1	Intravenous Injections 04/2013
1	Curettage 09/2009